Operating Room Equipment Market Is Going to Hit USD 48.50 Billion By 2025

San Francisco, 17 April 2019 –  “Operating Room Equipment Market Analysis By Product (Anesthesia Devices, Endoscopes, OR Tables, OR Lights, Electrosurgical Devices, Surgical Imaging Devices, Patient Monitors), By End-use, And Segment Forecasts, [2018 – 2025]”

The global operating room equipment market is expected to reach USD 48.50 billion by 2025 according to a new report by Grand View Research, Inc. The market is primarily driven by increasing investments for improving hospital care facilities, rising number of new hospitals & ambulatory care centers, increasing patient preference for minimally invasive procedures, and an increase in the number of surgeries performed globally.

Growing funds & investments by various government bodies and private investors are also contributing to the growth of the market. For instance, in its 2016-17 budget, the Hong Kong government dedicated a provision of USD 200 billion for a ten-year hospital development plan that would help expand and upgrade healthcare facilities. Under the plan, number of operating theaters would increase by 40% and specialist outpatient service capacity would increase by 40% from 6.8 million to 10 million attendances for a year. The development plan also includes redevelopment and expansion of various hospitals in the region.

Operating Room Equipment Market

In addition, a rapid increase in the number of elderly people & rising prevalence of chronic diseases are increasing the demand for surgical interventions and contributing to the expansion of the market. Technological innovations in medical devices are driving the adoption of advanced medical equipment in surgical procedures. Key players are focusing on product innovations and new launches to cope with growing needs.

Furthermore, improving healthcare infrastructure in emerging economies, large patient pool, and untapped opportunities in developing nations are attracting foreign investors to hospitals and the healthcare sector. Thus, growing investments in emerging economies and establishment of new hospitals & healthcare centers are expected to boost growth in the next few years.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/operating-room-equipment-market

Further Key Findings From the Report Suggest:

  • The anesthesia devices segment held majority of the revenue share in 2016 due to a rise in the volume of surgical procedures
  • Hospitals dominated the end-use segment in 2016 primarily due to increasing number of hospitals and rising investments in operating theaters
  • North America dominated the global market owing to a rapid increase in geriatric population and rising prevalence of various diseases
  • Some of the key players includeSTERIS plc; Stryker; KARL STORZ GmbH & Co. KG; GE Healthcare; Siemens Healthineers; and Hill-Rom (Trumpf Medical)

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the operating room equipment market on the basis of product, end-use, and region:

Operating Room Equipment Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Anesthesia Devices
  • Endoscopes
  • Operating Room Tables
  • Operating Room Lights
  • Electrosurgical Devices
  • Surgical Imaging Devices
  • Patient Monitors
  • Others

Operating Room Equipment End-Use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Ambulatory Surgical Centers

Operating Room Equipment Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-operating-room-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Joint Reconstruction Devices Market Projected to Surpass USD 30.4 Billion by 2025

San Francisco, 17 April 2019 –  “Joint Reconstruction Devices Market Analysis By Technique (Joint Replacement, Osteotomy, Arthroscopy, Resurfacing, Arthrodesis, Implants, Bone Graft), By Type (Knee, Hip, Shoulder, Ankle), & Segment Forecasts, [2018 – 2025]”

The global joint reconstruction devices market is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc. High adoption of minimally invasive surgeries across the globe has given rise to technological advancement in surgical devices and procedures. In addition, growing prevalence of joint-related conditions and changing therapeutic approaches are expected to boost the market growth.

The joint reconstruction devices market is largely dependent on technological development. Ongoing studies on improving robotically-assisted surgeries and bionic implants are expected to play a pivotal role in the development of total joint replacement surgeries market. These advancements are expected to help in complex surgeries to improve success rate of these procedures and increase patient convenience.

Joint Reconstruction Devices Market

A major share of the joint reconstruction market is captured by large joints. Knee and hip joint reconstruction together captured more than half of the revenue share in 2016. The prevalence of conditions related to these two joints is higher as compared to other joints due to overuse. Treatment of conditions related to these joints is crucial to recover the mobility of patients. Thus, a significant amount of funds are invested in R&D of large joint reconstruction techniques.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/joint-reconstruction-devices-market

Further key findings from the report suggest:

  • Joint replacement techniques captured the largest share in 2016 and is expected to maintain dominance throughout the forecast period. High procedural volume and high price of implants are anticipated to drive growth.
  • Development of operating techniques, allografts, and synthetic bone grafts are expected to boost growth of the bone graft segment. The segment is further divided into allograft and synthetic sub-segments.
  • The knee segment is expected to dominate the market throughout the forecast period. Availability of a large number of treatment options and introduction of innovative surgical techniques are expected to drive the growth of the segment.
  • Developing economies, increased foreign direct investment, rising demand, and emergence of local players are factors that are expected to render fastest growth in the Asia Pacific region.
  • Key players of the market include Medtronic; Nuvasive, Inc.; Zimmer Biomet; Stryker; DePuy Synthes; Aesculap Implant Systems, LLC; Smith and Nephew; CONMED Corporation; and DJO Global, Inc.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global joint reconstruction devices market on the basis of technique, joint type, and region:

Joint Reconstruction Devices Technique Outlook (Revenue, USD Million, 2014 – 2025)

  • Joint replacement
    • Implants
    • Bone Graft
      • Allograft
      • Synthetic
    • Osteotomy
    • Arthroscopy
    • Resurfacing
    • Arthrodesis
    • Others

Joint Reconstruction Devices Joint Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Knee
  • Hip
  • Shoulder
  • Ankle
  • Others

Joint Reconstruction Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-joint-reconstruction-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Neurovascular Devices Market Likely To Touch $3.1 Billion By 2026

San Francisco, 15 April 2019 –  “Neurovascular Devices Market Size, Share & Trends Analysis Report By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), By Device Type, By Region, And Segment Forecasts, [2019 – 2026]”

The global neurovascular devices market size is estimated to reach USD 3.1 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 5.3% over the forecast years. Preference for minimally invasive surgeries in the treatments of brain aneurysm and stroke is expected to be the key factor augmenting the market growth.

Technological advancements have increased life expectancy, leading to a consequent increase in geriatric population. According to a report published by United Nations, geriatric population (aged 60 years and above) is projected to increase by 56% from 901 million in 2015 to 1.4 billion by 2030. Therefore, rise in aging population across the globe is anticipated to impel the demand for neurovascular devices.

The market holds immense growth potential, and hence, manufacturers are focus on R&D to develop advanced products. Technological developments in the field of neurovascular therapy, such as development of GORE TIGRIS by W L Gore and SpiderFX distal filter embolic protection device by Medtronic, are expected to serve as a high impact rendering driver.

Neurovascular Devices Market

North America was the largest regional market in 2018 in terms of revenue and is expected to continue its dominance through the forecast period. Asia Pacific is anticipated to be the fastest-growing region with a CAGR of 6.0% in the estimated time. Wide adoption of innovative treatment approaches and growing per capita income, especially in the developing economies, are boosting the market growth in this region.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Further key findings from the study suggest:

  • Cerebral embolization and aneurysm coiling devices accounted for the majority of the global market share in 2018
  • In 2018, stroke was estimated to be the most prevalent therapeutic application for neurovascular devices
  • Cerebral aneurysm is projected to be the fastest-growing therapeutic application with a CAGR of 6.0% during the forecast period
  • Japan is a major revenue-generator in Asia Pacific region as nearly one in three Japanese people are older than 60 years
  • Key companies in this market include Abbott Laboratories; W. L. Gore & Associates, Inc.; Medtronic, Inc.; Stryker Corporation; and Merit Medical Systems, Inc.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global neurovascular devices market on the basis of device type, therapeutic applications, and region:

Neurovascular Device Type (Revenue, USD Million, 2014 – 2026)

  • Cerebral Embolization and Aneurysm Coiling
    • Embolic Coils
    • Flow Diversion
    • Liquid Embolic Agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid Artery Stents
    • Embolic Protection Systems
  • Neurothrombectomy
    • Clot Retrieval
    • Suction
    • Vascular Snares
  • Support
    • Micro Catheters
    • Micro Guidewires

Neurovascular Devices Therapeutic Application Outlook (Revenue, USD Million, 2014 – 2026)

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2014 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
  • Asia Pacific
    • Japan
    • India
    • South Korea
    • China
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-neurovascular-devices-market-size-report

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Surgical Robot Market Worth to Excel USD 20.8 Billion by 2024

The global surgical robot market is expected to reach USD 20.8 billion by 2024, according to a new study by Grand View Research, Inc. The prevalence of chronic disorders, such as chronic heart diseases and various types of cancer, is on a rise. These diseases frequently require surgery as a line of treatment. With the advent of surgical robot, these surgeries have become easier and less traumatic, thereby propelling the demand over the forecast period.

The surgical robotic system causes less postoperative complications and reduces the length of hospital stay for a patient. This further helps to save treatment cost as well as labor cost. Owing to these benefits, these devices are now favored by hospitals in developing as well as developed regions.

The introduction of evolved systems is expected to boost the market growth over the forecast period. The development of computer software coupled with such robotic systems result in higher precision and better viewing of the incision site. This is expected to propel the demand over the forecast period.

Surgical Robot Market

The rising popularity of minimally invasive procedures due to their patient-friendly nature is the vital driver for this industry. Surgical robot help in performing complicated procedures through navigation and magnification options.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/surgical-robot-market

Further key findings from the study suggest:

  • Robot systems held a lucrative share of around 42.0% in the product segment. Robot systems were followed by accessories and are also anticipated to witness a substantial growth owing to their frequent repurchase.
  • On the other hand, services are anticipated to grow at a lucrative rate of around 20.0% over the forecast period. Periodic maintenance of the existing robotic systems is mandatory; hence, this segment is anticipated to witness a substantial growth.
  • The da Vinci Surgical System by Intuitive Surgical, Inc. dominated this industry in 2015. This system is the first U.S.FDA approved system; hence, retains the first mover advantage.
  • ROSA surgical system by Medtech is anticipated to witness a lucrative growth over the forecast period. These systems are intended for the brain and spinal cord surgeries. Recent approval for ROSA systems as well as expansion in European and North American Region by Medtech is anticipated to support the growth of this system.
  • Gynecology held significant share of around 30.0% in application segment followed by general surgery segment which is anticipated to witness remunerative share over the forecast period. Rising prevalence of colorectal cancer further contributed towards the growth of this segment.
  • North America is the dominating market with lucrative shares of around 60.0% in 2015. However, Asia Pacific is projected to witness sturdy growth over the forecast period with the fastest growth rate. Healthcare advancements as well economic developments with the aid of government is anticipated to support the growth.
  • The key players operating in this industry include Intuitive Surgical, Inc., Accuray, MAKO /Stryker, Medtech Surgical, Hansen Medical, TransEntrix, Titan Medical, Inc., and Renishaw Plc.
  • New product launches and collaborative developments are key strategic initiatives undertaken by market players to sustain the competition
  • For instance, in July 2015, Accuray and Raysearch Laboratories AB formed a strategic collaboration. Accuray will co-market and offer Raycare Oncology Information System (OIS) in designated major radiation markets

Related Report of Medical Devices:

Grand View Research has segmented the global surgical robot market on the basis of type, products, and region:

Global Surgical Robots Market By Product, 2014 – 2024 (USD Million)

  • Robot System
  • Instrument & Accessories
  • Services

Global Surgical Robots Market By Brand, 2014 – 2024 (USD Million)

  • da Vinci Surgical System
  • CyberKnife
  • ROSA
  • MAKO
  • Renaissance
  • Other

Global Surgical Robots Market By Application, 2014 – 2024 (USD Million)

  • General Surgery
  • Urology
  • Orthopedic
  • Neurosurgery
  • Cardiovascular
  • Gynecology
  • Radiology
  • Transplant
  • Gastrointestinal
  • Others

Surgical Robots Market By Region, 2014 – 2024 (USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Access Press Release of This Research Report by Grand View Research:
www.grandviewresearch.com/press-release/global-surgical-robot-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James         

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

For More Info: www.grandviewresearch.com

Transcatheter Heart Valve Market Valuation to Exceed USD 8.6 Billion by 2024

The global transcatheter heart valve market is anticipated to reach a value of USD 8.62 billion by 2024, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

Transcatheter Heart Valve Market

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/transcatheter-valve-market

Further Key Findings from the Study Suggest:

  • Aortic stenosis is the most prevalent valve disease, and if untreated it can lead to death. In 2015, transcatheter aortic valve segment accounted for the maximum revenue of over USD 1.6 billion and is expected to retain its dominant share over the forecast period.
  • However, the transcatheter mitral valve segment is expected to emerge as the fastest growing with a CAGR of 23% over the forecast period. Increasing number of elderly patients with mitral regurgitation and growing demand for technologically advanced transcatheter valve devices are expected to drive the usage of transcatheter mitral valves over the forecast period.
  • In 2015, the self-expanded transcatheter accounted for the largest market share of 65%. These catheters are most commonly used and, currently, most of the products that are available in the market are based on this technology. However, balloon expanded transcatheters are expected to have the fastest CAGR of 16.8% over the forecast period.
  • North America held the maximum share of nearly49% in 2015. A combination of different factors such as the presence of large target population, high disposable income, strong reimbursement framework, contribute toward the high revenue generated in this region.
  • Asia Pacific is anticipated to register the fastest CAGR of 17.8% over the forecast period. Increasing disease burden, improvement in clinical trial regulations, growing preference for advanced medical technologies, increase in medical tourism, and special incentives for investments in healthcare sector are expected to strongly favor the growth in this region.
  • Some key market players Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis. ValveXchange, Edwards Lifesciences, and Medtronic are the early movers in this market have captured significant market share in the North America, Europe, and the Asia Pacific region.

Related Report of Medical Devices:

Grand View Research has segmented the transcatheter heart valve market by application, technology and region:

Transcatheter Heart Valve Market Application Outlook (Market revenue in USD Million, 2013 – 2024)

  • Transcatheter aortic valve
  • Transcatheter pulmonary valve
  • Transcatheter mitral valve

Transcatheter Heart Valve Market Technology Outlook (Market revenue in USD Million, 2013 – 2024)

  • Balloon expanded transcatheter valve
  • Self-expanded transcatheter valve

Transcatheter Heart Valve Market Regional Outlook, (Market Revenue in USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release of This Research Report by Grand View Research:
www.grandviewresearch.com/press-release/global-squalene-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Info: www.grandviewresearch.com

Neurorehabilitation Devices Market Poised To Reach $3.2 Billion By 2024

San Francisco, 09 April 2019 –  “Neurorehabilitation Devices Market By Products (Neurorobotics, Brain-Computer Interface, Wearable Devices, Noninvasive Stimulators), By Therapy Area (Stroke, Multiple Sclerosis, Parkinson’s Disease, Cerebral Palsy, Others – Brain And Spinal Cord Injury), And Segment Forecasts To 2024”

The global neurorehabilitation devices market in 2015 was valued at USD 915.1 million and is estimated to reach USD 3.2 billion by 2024. Around 1 billion people are suffering from neurological disorders across the globe. These neurological disorders are resulting in increased movement disabilities. The increasing prevalence of movement disability, attributed to various neurological disorders (multiple sclerosis, stroke, etc) along with need for comprehensive management is the key factors driving the market growth.

Every year around 15 million people suffer from stroke globally, of which 5 million people are affected by permanent disability. Each year Multiple sclerosis and Parkinson’s disease affect 2.5 million and 10 million patients respectively worldwide. The increasing prevalence and incidence rates of neurological disorders create a huge demand for neurorehab devices, as they ensure simplification of routine tasks for the disabled patients by reducing their dependency on others.

Furthermore, the rising awareness of neurorehab services among the care providers is contributing to the increasing adoption of these devices. In addition, consistent technological advancements are leading to introduction and commercialization of novel products in this sector. Majority of the manufacturers and distributors of neurorehab platforms are headquartered in North America region. North America dominates the market followed by Europe attributed to the rising awareness and increased adoption of novel technologies in these regions. Asia Pacific is growing at the highest CAGR among all the regions due to increasing target population and improving healthcare infrastructure.

Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy. Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players. For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.

Neurorehabilitation Devices Market

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/neurorehabilitation-devices-market

Further Key Findings from the Study Suggest:

  • Neurorobotics is expected to be one of the most lucrative segments in the coming years owing to the high availability of exoskeletons and prosthetics targeted for treating movement disabilities. Bioness, Inc. and Hocoma AG are few of the key manufacturers of exoskeletons and prosthetics.
  • Consistent technological sophistications in brain stimulations and machine learning brain-computer interface segment is expected to develop tremendously.
  • Non invasive stimulators have the potential to modulate brain plasticity. In February 2016, USFDA approved Medtronic’s brain stimulation therapy in the treatment of Parkinson’s disease.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the neurorehabilitation devices market by products, therapy area, and region:

Products Outlook (Market revenue in USD Million, 2013 – 2024)

  • Neurorobotics
  • Brain-computer interface
  • Wearable devices
  • Non-invasive Stimulators

Therapy Area Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Stroke
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Cerebral Palsy
  • Others

Regional Outlook (Market Revenue in USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-neurorehabilitation-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Durable Medical Equipment Market Size To Reach $271.0 Billion By 2026

The global durable medical equipment (DME) market size is expected to reach USD 271.0 billion by 2026 registering a CAGR of 6.1%, according to a new report by Grand View Research, Inc. The market is primarily driven by rise in chronic diseases, such as kidney failures and cancer. Moreover, technological advancements along with strong reimbursement scenario will boost the DME market further. For instance, in January 2019, WHILL, Inc., a U.S.-based personal electric vehicle, introduced new technology WHILL autonomous drive at the Consumer Electronic Sow held at the Las Vegas. In the past, Medicare has taken steps to bring reimbursement of DME products in line with other payers.

In this direction, in December 2015, the Center for Medicare & Medicare Services (CMS) issued a new rule of prior authorization process for DME, Prosthetics, Orthotics, and Supplies (DMEPOS). The DMEPOS includes the master list of 135 items, which require prior authorization before beneficiary receives an item. In addition, growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and lack of skilled professionals may limit the durable medical equipment market growth.

Durable-Medical-Equipment

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/durable-medical-equipment-dme-market

Further key findings from the study suggest:

  • Personal mobility devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability
  • Nursing homes is anticipated to be the fastest-growing segment over the study period as these facilities offer custodial care like skilled care, such as bathing and dressing
  • Europe led the market with the largest share in 2018 and will witness a steady growth in future on account of the presence of major companies in the region
  • Asia Pacific is expected to register the highest CAGR from 2019 to 2026 owing to the presence of a large target population base and improving healthcare facilities
  • Some of the key companies in the global DME market are Invacare Corporation; ArjoHuntleigh; Stryker Corporation; Hill Rom, Inc.; Drive Medical; GF Health Products, Inc.; Sunrise Medical; Medline Industries, Inc.; and Carex Health Brands, Inc.

Related Report of Medical Devices: 

Grand View Research has segmented the global Durable Medical Equipment (DME) market on the basis of product, end use, and region:

DME Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Personal Mobility Devices
    • Wheelchairs
    • Scooters
    • Walker and Rollators
    • Cranes and Crutches
    • Door Openers
    • Other Devices
  • Bathroom Safety Devices and Medical Furniture
    • Commodes and Toilets
    • Mattress and Bedding Devices
  • Monitoring and Therapeutic Devices
    • Blood Sugar Monitors
    • Continuous Passive Motion (CPM)
    • Infusion Pumps
    • Nebulizers
    • Oxygen Equipment
    • Continuous Positive Airway Pressure (CPAP)
    • Suction Pumps
    • Traction Equipment
    • Others Equipment

DME End Use Outlook (Revenue, USD Million, 2015 – 2026)

  • Hospital
  • Nursing Homes
  • Home Healthcare
  • Other

DME Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Access Press Release of This Research Report by Grand View Research:
www.grandviewresearch.com/press-release/global-durable-medical-equipment-dme-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Info: www.grandviewresearch.com